Amarin Not Backing Down In Free Speech Suit Against FDA
Amarin Pharma Inc. on Tuesday urged a New York federal judge to protect its off-label marketing of fish oil drug Vascepa, saying the U.S. Food and Drug Administration hasn't removed the...To view the full article, register now.
Already a subscriber? Click here to view full article